OAM
REGN icon

Oxford Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Oxford Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-550
Closed -$349K – 726
2025
Q1 		$349K Buy
550
+207
+60% +$142K 0.16% 217
2024
Q4 		$244K Buy
+343
New +$288K 0.11% 309
2024
Q1 		– Sell
-704
Closed -$618K – 341
2023
Q4 		$618K Buy
+704
New +$580K 0.93% 24
2020
Q1 		– Sell
-4,252
Closed -$1.6M – 1059
2019
Q4 		$1.6M Buy
+4,252
New +$1.43M 0.04% 562
2019
Q3 		– Sell
-1,214
Closed -$380K – 1915
2019
Q2 		$380K Sell
1,214
-18,929
-94% -$6.3M 0.01% 1377
2019
Q1 		$8.27M Buy
+20,143
New +$8.29M 0.18% 127
2018
Q4 		– Sell
-769
Closed -$312K – 2042
2018
Q3 		$312K Sell
769
-364
-32% -$139K 0.01% 1485
2018
Q2 		$393K Sell
1,133
-1,766
-61% -$552K 0.01% 1425
2018
Q1 		$998K Buy
2,899
+143
+5% +$49.7K 0.02% 942
2017
Q4 		$1.05M Buy
+2,756
New +$1.12M 0.02% 904
2014
Q4 		– Sell
-5,733
Closed -$2.06M – 767
2014
Q3 		$2.06M Buy
+5,733
New +$1.92M 0.05% 366

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Oxford Asset Management's REGN Position: Q2 2025 in Review

Oxford Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 550 shares — an estimated $349K sold.

Oxford Asset Management first reported a position in REGN in Q3 2014 and held it in 11 quarters. The position peaked at $8.27M in Q1 2019. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Oxford Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 550 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $349K.
  • Oxford Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 11 quarters.
  • Oxford Asset Management's Regeneron Pharmaceuticals position peaked at $8.27M in Q1 2019.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.